| Operating Activities |
| Net income |
1.09B |
| Depreciation and amortization |
551M |
| Stock-based compensation expense |
77M |
| Cash payments for restructuring charges |
-30M |
| Merger and integration costs |
| Cash payments for merger and integration costs |
-11M |
| Gain on previously held equity interests in The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) |
| Asset write-off |
| Non-cash foreign exchange loss related to Venezuela devaluation |
111M |
| Excess tax benefits from share-based payment arrangements |
-36M |
| Pension and retiree medical plan contributions |
-87M |
| Pension and retiree medical plan expenses |
149M |
| Bottling equity income, net of dividends |
| Deferred income taxes and other tax charges and credits |
-23M |
| Change in accounts and notes receivable |
-175M |
| Change in inventories |
-351M |
| Change in prepaid expenses and other current assets |
-201M |
| Change in accounts payable and other current liabilities |
-578M |
| Change in income taxes payable |
244M |
| Other, net |
| Net Cash Provided by Operating Activities |
702M |
| Investing Activities |
| Capital spending |
-303M |
| Sales of property, plant and equipment |
8M |
| Acquisition of manufacturing and distribution rights from Dr Pepper Snapple Group, Inc. (DPSG) |
| Investment in WBD |
| Other acquisitions and investments in noncontrolled affiliates |
-30M |
| Short-term investments, by original maturity |
| More than three months - purchases |
| More than three months - maturities |
| Three months or less, net |
40M |
| Other investing, net |
0 |
| Net Cash Used For Investing Activities |
-285M |
| Financing Activities |
| Proceeds from issuances of long-term debt |
2.49B |
| Payments of long-term debt |
-1.19B |
| Short-term borrowings, by original maturity |
| More than three months - proceeds |
5M |
| More than three months - payments |
-464M |
| Three months or less, net |
306M |
| Cash dividends paid |
-831M |
| Share repurchases - common |
-626M |
| Share repurchases - preferred |
-2M |
| Proceeds from exercises of stock options |
449M |
| Excess tax benefits from share-based payment arrangements |
36M |
| Acquisition of noncontrolling interests |
| Other financing |
-1M |
| Net Cash (Used for)/Provided by Financing Activities |
173M |
| Effect of exchange rate changes on cash and cash equivalents |
-172M |
| Net (Decrease)/Increase in Cash and Cash Equivalents |
418M |
| Cash and Cash Equivalents, Beginning of Year |
6.3B |
| Cash and Cash Equivalents, End of Period |
6.72B |
| Non-cash activity: |
| Issuance of common stock and equity awards in connection with our acquisitions of PBG and PAS, as reflected in investing and financing activities |
| PBG and PAS Acquisition [Member] |
| Operating Activities |
| Merger and integration costs |
| Investing Activities |
| Acquisitions, net of cash and cash equivalents acquired |
| Wimm-Bill-Dann [Member] |
| Investing Activities |
| Acquisitions, net of cash and cash equivalents acquired |
